BACKGROUND: A proposed mechanism of intestinal injury in necrotizing enterocolitis (NEC) involves vascular dysfunction through altered nitric oxide synthase (NOS) activity. We hypothesize that this dysfunction results in an imbalance in nitric oxide (*NO) and superoxide (O(2)(*-)) production by the intestinal vascular endothelium, which contributes to the intestinal injury seen in NEC. MATERIALS AND METHODS: Neonatal rat pups were divided into two groups. Control pups were breast fed and housed with their mother. Experimental NEC pups were housed separately and either exposed to formula feeding and 5% to 10% hypoxia alone (FF/H) or with the addition of lipopolysaccharide (FF/H/LPS). Mesenteries from each group were analyzed for *NO and O(2)(*-) production with and without NOS inhibition by N(G)-monomethyl-L-arginine (L-NMMA). Western blot analysis for eNOS, phosphorylated eNOS (phospho-eNOS), and inducible NOS (iNOS) was performed, and each terminal ileum was graded for intestinal injury by histology. RESULTS: Histology revealed mild intestinal injury (grade 1-2 on a 4-point scale) in the FF/H group and severe injury (grade 3-4) in the FF/H/LPS group. The FF/H cohort had significantly increased *NO and lower O(2)(*-) production, while the FF/H/LPS group shifted to significantly decreased *NO and increased O(2)(*-) production. L-NMMA inhibited >50% of O(2)(*-) production in all three groups but only inhibited *NO production in control and FF/H pups. Western blot analysis revealed increased levels of phospho-eNOS in FF/H pups and increased iNOS in FF/H/LPS pups. CONCLUSIONS: This study demonstrates in the progression of NEC, intestinal ischemia is associated with a shift from *NO to O(2)(*-) production, which is NOS-dependent. Potentially greater injury results from impaired vasodilatation and over-production of reactive oxygen species. Copyright (c) 2010 Elsevier Inc. All rights reserved.
BACKGROUND: A proposed mechanism of intestinal injury in necrotizing enterocolitis (NEC) involves vascular dysfunction through altered nitric oxide synthase (NOS) activity. We hypothesize that this dysfunction results in an imbalance in nitric oxide (*NO) and superoxide (O(2)(*-)) production by the intestinal vascular endothelium, which contributes to the intestinal injury seen in NEC. MATERIALS AND METHODS: Neonatal rat pups were divided into two groups. Control pups were breast fed and housed with their mother. Experimental NEC pups were housed separately and either exposed to formula feeding and 5% to 10% hypoxia alone (FF/H) or with the addition of lipopolysaccharide (FF/H/LPS). Mesenteries from each group were analyzed for *NO and O(2)(*-) production with and without NOS inhibition by N(G)-monomethyl-L-arginine (L-NMMA). Western blot analysis for eNOS, phosphorylated eNOS (phospho-eNOS), and inducible NOS (iNOS) was performed, and each terminal ileum was graded for intestinal injury by histology. RESULTS: Histology revealed mild intestinal injury (grade 1-2 on a 4-point scale) in the FF/H group and severe injury (grade 3-4) in the FF/H/LPS group. The FF/H cohort had significantly increased *NO and lower O(2)(*-) production, while the FF/H/LPS group shifted to significantly decreased *NO and increased O(2)(*-) production. L-NMMA inhibited >50% of O(2)(*-) production in all three groups but only inhibited *NO production in control and FF/H pups. Western blot analysis revealed increased levels of phospho-eNOS in FF/H pups and increased iNOS in FF/H/LPS pups. CONCLUSIONS: This study demonstrates in the progression of NEC, intestinal ischemia is associated with a shift from *NO to O(2)(*-) production, which is NOS-dependent. Potentially greater injury results from impaired vasodilatation and over-production of reactive oxygen species. Copyright (c) 2010 Elsevier Inc. All rights reserved.
Authors: Bohuslav Dvorak; Melissa D Halpern; Hana Holubec; Catherine S Williams; Debra L McWilliam; Jessica A Dominguez; Renata Stepankova; Claire M Payne; Robert S McCuskey Journal: Am J Physiol Gastrointest Liver Physiol Date: 2002-01 Impact factor: 4.052
Authors: K L Chan; Connie W C Hui; K W Chan; Peter C W Fung; Jana Y H Wo; G Tipoe; Paul K H Tam Journal: J Pediatr Surg Date: 2002-06 Impact factor: 2.545
Authors: Harish J Amin; Samuel A Zamora; Douglas D McMillan; Gordon H Fick; J Decker Butzner; Howard G Parsons; R Brent Scott Journal: J Pediatr Date: 2002-04 Impact factor: 4.406
Authors: Tomasz J Guzik; Shafi Mussa; Daniela Gastaldi; Jerzy Sadowski; Chandi Ratnatunga; Ravi Pillai; Keith M Channon Journal: Circulation Date: 2002-04-09 Impact factor: 29.690
Authors: Hanke Mollnau; Eberhard Schulz; Andreas Daiber; Stephan Baldus; Matthias Oelze; Michael August; Maria Wendt; Ulrich Walter; Carolin Geiger; Rahul Agrawal; Andrei L Kleschyov; Thomas Meinertz; Thomas Münzel Journal: Arterioscler Thromb Vasc Biol Date: 2003-03-06 Impact factor: 8.311
Authors: Elizabeth R Jacobs; Sreedhar Bodiga; Irshad Ali; Aaron M Falck; John R Falck; Meetha Medhora; Anuradha Dhanasekaran Journal: Exp Cell Res Date: 2012-06-09 Impact factor: 3.905
Authors: Ben E Biesterveld; Shannon M Koehler; Nathan P Heinzerling; Rebecca M Rentea; Katherine Fredrich; Scott R Welak; David M Gourlay Journal: J Surg Res Date: 2015-02-19 Impact factor: 2.192
Authors: Jason Fawley; Alain Cuna; Heather L Menden; Steven McElroy; Shahid Umar; Scott R Welak; David M Gourlay; Xiaoxia Li; Venkatesh Sampath Journal: Pediatr Res Date: 2017-10-04 Impact factor: 3.756
Authors: Priti Pun; Jesica Jones; Craig Wolfe; Douglas D Deming; Gordon G Power; Arlin B Blood Journal: Pediatr Res Date: 2015-11-05 Impact factor: 3.756
Authors: Scott R Welak; Rebecca M Rentea; Ru-Jeng Teng; Nathan Heinzerling; Ben Biesterveld; Jennifer L Liedel; Kirkwood A Pritchard; Katherine M Fredrich; David M Gourlay Journal: PLoS One Date: 2014-12-17 Impact factor: 3.240